title: Magnetization transfer contrast-prepared MR imaging of the liver: inability to distinguish healthy from cirrhotic liver.
abstract: OBJECTIVE
  To evaluate the ability of magnetization transfer (MT) contrast-prepared magnetic resonance (MR) imaging to help distinguish healthy from cirrhotic liver by using a spectrum of MT pulse frequency offsets.
  
  
  METHODS
  This HIPAA-compliant prospective study was approved by the institutional review board. Written informed consent was obtained from all subjects. After optimization of the MT sequence by using agar phantoms with protein concentrations ranging from 0% to 4%, 20 patients with cirrhosis and portal hypertension and 20 healthy volunteers with no known liver disease underwent liver MR imaging that included eight separate breath-hold MT contrast sequences, each performed by using a different MT pulse frequency offset (range, 200-2500 Hz). Regions of interest were then placed to calculate the MT ratio for the liver, fat, and muscle in the volunteer group and for the liver in the cirrhosis group.
  
  
  RESULTS
  MT ratio increased with decreasing MT pulse frequency offset for each of the four phantoms and the assessed in vivo tissues, consistent with previous reports. At all frequency offsets, MT ratio increased with increasing phantom protein concentration. In volunteers, at frequency offsets greater than 400 Hz, the MT ratio was significantly greater for muscle (range, 34.4%-54.9%) and significantly lower for subcutaneous fat (range, 10.3%-12.6%), compared with that for the liver (range, 22.8%-46.9%; P < .001 all comparisons). However, the MT ratio was nearly identical between healthy (range, 26.0%-80.0%) and cirrhotic livers (range, 26.7%-81.2%) for all frequency offsets (P = .162-.737), aside from a minimal difference in MT ratio of 1.7% at a frequency offset of 2500 Hz (22.8% in healthy liver vs 24.5% in cirrhotic liver) that was not significant when the Bonferroni correction was applied (P = .015).
  
  
  CONCLUSIONS
  Findings of this study confirm the ability of the MT contrast-prepared sequence to help distinguish substances of varying protein concentration and suggest that MT imaging is unlikely to be of clinical utility in differentiating healthy and cirrhotic livers.
authors: Department of Radiology, NYU School of Medicine, 560 First Ave, TCH-HW202, New York, NY 10016, USA. Andrew.Rosenkrantz@nyumc.org
authors: Andrew B
authors: AB
authors: Rosenkrantz
authors: Pippa
authors: P
authors: Storey
authors: Anthony G
authors: AG
authors: Gilet
authors: Benjamin E
authors: BE
authors: Niver
authors: James S
authors: JS
authors: Babb
authors: Cristina H
authors: CH
authors: Hajdu
authors: Vivian S
authors: VS
authors: Lee
mesh_terms: D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003287:Contrast Media; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006975:Hypertension, Portal / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D007090:Image Interpretation, Computer-Assisted; D008103:Liver Cirrhosis / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D016031:Liver Transplantation; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D019047:Phantoms, Imaging; D011446:Prospective Studies; D012720:Severity of Illness Index; D015996:Survival Rate
chemical_list: D003287:Contrast Media